25 juni 2026 Sweden
BioStock: Anders Essen-Möller on Diamyd’s darkest hour
”Times are really tough currently. Whilst I do not wish anybody to go through what we currently are experiencing, I feel the need to step in as the CEO. At least for a short while. Yes, I am an old man. But with some experience.” So writes Anders Essen-Möller in his CEO statement in Diamyd Medical’s Q3 report. It is an unusually candid letter from a founder stepping back in at the helm of a company he built, at a moment when it stands at a crossroads.
Read the article here
Information som presenteras här är inte pressmeddelanden och kan innehålla utdrag ur och länkar till externt publicerat innehåll. Diamyd Medical ansvarar inte för externt publicerat innehåll.